FDA Approves OXYCODONE HYDROCHLORIDE — PAI Holdings, LLC dba PAI Pharma
PAI Holdings, LLC dba PAI Pharma announced the approval of an abbreviated new drug application (ANDA206914) for OxyCODONE HYDROCHLORIDE oral dosage form, increasing generic competition for the brand name opioid Painkilling medication. This designation threatens the commercial exclusivity of the leading brand product by broadening market availability and driving price erosion.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed